Ascendis Pharma
ASND
ASND
129 hedge funds and large institutions have $4.44B invested in Ascendis Pharma in 2019 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 39 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
5.95% less ownership
Funds ownership: 102.94% → 97% (-5.9%)
13% less funds holding in top 10
Funds holding in top 10: 16 → 14 (-2)
19% less capital invested
Capital invested by funds: $5.49B → $4.44B (-$1.04B)
Holders
129
Holding in Top 10
14
Calls
$109M
Puts
$18.5M
Top Buyers
| 1 | +$65M | |
| 2 | +$57.5M | |
| 3 | +$52.6M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$31.4M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$14.7M |
Top Sellers
| 1 | -$237M | |
| 2 | -$54.5M | |
| 3 | -$44.1M | |
| 4 |
VMI
VHCP Management II
New York
|
-$26M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$19.3M |